Inmune Bio (INMB) Other Gross PP&E Adjustments (2019 - 2025)
Inmune Bio's Other Gross PP&E Adjustments history spans 7 years, with the latest figure at -$1.1 million for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments fell 217.61% year-over-year to -$1.1 million; the TTM value through Sep 2025 reached -$1.1 million, down 217.61%, while the annual FY2024 figure was -$2.4 million, 6.6% up from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was -$1.1 million at Inmune Bio, down from -$374000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$128000.0 in Q3 2021 and bottomed at -$2.6 million in Q4 2023.
- The 5-year median for Other Gross PP&E Adjustments is -$485000.0 (2023), against an average of -$760842.1.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 374.45% in 2022 before it surged 33.2% in 2025.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$795000.0 in 2021, then plummeted by 138.11% to -$1.9 million in 2022, then plummeted by 38.51% to -$2.6 million in 2023, then grew by 6.6% to -$2.4 million in 2024, then soared by 56.55% to -$1.1 million in 2025.
- Per Business Quant, the three most recent readings for INMB's Other Gross PP&E Adjustments are -$1.1 million (Q3 2025), -$374000.0 (Q2 2025), and -$324000.0 (Q1 2025).